Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Diagn Microbiol Infect Dis ; 38(3): 171-2, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11109016

RESUMEN

A man with AIDS developed appendicitis and bacteremia caused by Group A streptococcus, neither of which is considered an opportunistic infection. Group A streptococcus is rarely implicated in appendicitis in children and has not previously been reported in an adult. Immunodeficiency might have predisposed the patient to this unusual infection.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Apendicitis/complicaciones , Apendicitis/microbiología , Infecciones Estreptocócicas/complicaciones , Streptococcus pyogenes/aislamiento & purificación , Síndrome de Inmunodeficiencia Adquirida/microbiología , Adulto , Bacteriemia/complicaciones , Bacteriemia/microbiología , Humanos , Masculino , Infecciones Estreptocócicas/microbiología
2.
Proc Natl Acad Sci U S A ; 91(23): 10987-91, 1994 Nov 08.
Artículo en Inglés | MEDLINE | ID: mdl-7971996

RESUMEN

The adenovirus (Ad) 14.7-kDa protein, which is called "14.7K," has been shown to function as a general inhibitor of tumor necrosis factor alpha (TNF) cytolysis in tissue culture assays, and the effect of this antagonism on viral pathogenesis in vivo has recently been explored. In infections of immunocompetent BALB/c mice, we have shown previously that Ad type 2 (Ad2) 14.7K, when cloned into a vaccinia virus (VV) vector in combination with the gene for murine TNF, is able to counteract much of the attenuating effect of TNF on VV virulence. In the present study we utilized VV constructs expressing various combinations of Ad 14.7K and TNF in infections of T- and B-cell-deficient C.B-17 severe combined immunodeficient (SCID) mice to determine whether these cells are directly necessary for 14.7K's reversal of TNF-mediated viral attenuation. The mice were infected by the intranasal route, and mortality, morbidity, histopathology, and virus replication in selected organs were evaluated at various times after infection. We found that, in the SCID murine pneumonia model, neither the attenuation by TNF nor its reversal by Ad 14.7K require the participation of T or B lymphocytes or their secreted products. SCID mice infected with VV expressing both 14.7K and TNF [VV 14.7(+)/TNF] were generally well clinically for the first 7-10 days after infection; however, they developed a subacute or chronic illness, succumbing to diseminated VV infection at least 3 weeks earlier than mice infected with VV expressing TNF alone [VV 14.7(-)/TNF]. Animals infected with VV 14.7(+)/TNF were shown to have higher initial titers of virus and delayed clearance from the lungs as well as more rapid spread of virus to internal organs than animals infected with VV 14.7(-)/TNF. SCID mice infected intranasally with VV without TNF showed a dramatic increase in acute disease and succumbed within the first 1-2 weeks after infection, independent of Ad 14.7K expression.


Asunto(s)
Proteínas E3 de Adenovirus/toxicidad , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Virus Vaccinia/patogenicidad , Animales , Secuencia de Bases , Enfermedad Crónica , Cartilla de ADN/química , Expresión Génica , Genes , Linfocitos/inmunología , Ratones , Ratones SCID , Datos de Secuencia Molecular , Neumonía Viral/microbiología , Factor de Necrosis Tumoral alfa/genética , Vaccinia/inmunología , Vaccinia/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA